G1 Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.953; its P/E ratio is -4.30; G1 Therapeutics is scheduled to report earnings on May 1, 2024, and the estimated EPS forecast is $-0.20. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	$ 12.30M	$ 42.39M	$ 12.95M	$ 10.25M	$ 23.58M
Gross Profit	$ 12.30M	$ 42.39M	$ 12.95M	$ 10.25M	$ 22.46M
EBIT	$ -17.30M	$ 10.02M	$ -27.59M	$ -33.17M	$ -21.29M
EBITDA	$ -17.47M	$ 9.86M	$ -27.43M	-	$ -21.15M
Net Income Common Stockholders	$ -18.20M	$ 8.71M	$ -27.59M	$ -33.65M	$ -25.27M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 94.35M	$ 104.29M	$ 116.38M	$ 145.13M	$ 122.98M
Total Assets	$ 133.10M	$ 147.89M	$ 161.96M	$ 187.97M	$ 166.57M
Total Debt	$ 55.92M	$ 55.93M	$ 82.78M	$ 82.63M	$ 82.47M
Net Debt	$ -38.43M	$ -48.36M	$ -33.60M	$ -62.50M	$ -40.51M
Total Liabilities	$ 90.08M	$ 90.34M	$ 116.97M	$ 187.98M	$ 120.61M
Stockholders Equity	$ 43.02M	$ 57.55M	$ 44.99M	$ 68.77M	$ 45.97M
Cash Flow	-
Free Cash Flow	$ -10.58M	$ 14.09M	$ -29.05M	$ -30.63M	$ -21.25M
Operating Cash Flow	$ -10.58M	$ 14.09M	$ -29.05M	$ -30.63M	$ -21.25M
Investing Cash Flow	$ 7.20M	$ 346.00K	$ 2.91M	$ -20.36M	$ -29.66M
Financing Cash Flow	$ 22.00K	$ -26.75M	$ -214.00K	$ 52.35M	$ 127.00K

Currency in USD

G1 Therapeutics Earnings and Revenue History

Income Statement >

G1 Therapeutics Debt to Assets

Balance Sheet >

G1 Therapeutics Cash Flow

Cash Flow >

G1 Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing